- JNJ -1.39%
Johnson & Johnson's Dividend Analysis
Yahoo Finance · 19 hours ago
Open | 153.10 |
High | 153.39 |
Low | 151.26 |
Mkt Cap | 364.06B |
P/E (TTM) | 22.48 |
Div & Yield | 4.96 & 3.28% |
Prev. Close | 153.40 |
52 Wk. Low | 143.13 |
52 Wk. High | 175.97 |
Related stocks
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
Johnson & Johnson is an American multinational, pharmaceutical, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 21.38B | 2.30% ▲ |
Net Income | 3.25B | - |
Diluted EPS | 2.49 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | $2.49 | - |
Q1 2024 | $2.42 | $2.49 |
Q4 2023 | $2.28 | $2.29 |
S&P FuturesES=F | 5,333.00+1.25 (+0.02%) |
Dow FuturesYM=F | 39,948.00+4.00 (+0.01%) |
Nasdaq FuturesNQ=F | 18,749.25-13.75 (-0.07%) |
323.77+1.86% | |
Ethereum USDETH-USD | 3,644.50+16.63% |
48.38-4.98% |